Author:
Karadoğan Dilek,Ünsal Meftun
Publisher
Springer International Publishing
Reference71 articles.
1. Nasim F, Sabath BF, Eapen GA. Lung cancer. Med Clin North Am. 2019;103(3):463–73. https://doi.org/10.1016/j.mcna.2018.12.006.
2. Bryan S, Masoud H, Weir HK, et al. Cancer in Canada: stage at diagnosis. Health Rep. 2018;29(12):21–5.
3. Önal Ö, Koçer M, Eroğlu HN, et al (2020) Survival analysis and factors affecting survival in patients who presented to the medical oncology unit with non-small cell lung cancer. Turk J Med Sci. https://doi.org/10.3906/sag-1912-205.
4. Göksel S, Karadoğan D. Prevalence and predictors of symptoms in lung cancer patients staged at diagnosis by 18 FDG PET/CT. Turk Thorac J. 2019;20:Supplement 219. https://doi.org/10.5152/TurkThoracJ.2019.219.
5. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Non-small cell lung cancer. NCCN Version 6.2020-June 15, 2020.